Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | CTNNB1 |
Variant | S45del |
Impact List | deletion |
Protein Effect | gain of function |
Gene Variant Descriptions | CTNNB1 S45del results in the deletion of an amino acid at a Gsk3b phosphorylation site of the Ctnnb1 protein at amino acid 45 (PMID: 9065402). S45del confers a gain of function to the Ctnnb1 protein as demonstrated by stabilization and nuclear accumulation of Ctnnb1 (PMID: 9065402, PMID: 21084400). |
Associated Drug Resistance | |
Category Variants Paths |
CTNNB1 mutant CTNNB1 act mut CTNNB1 S45del |
Transcript | NM_001098210.2 |
gDNA | chr3:g.41224645_41224647delTCT |
cDNA | c.133_135delTCT |
Protein | p.S45delS |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_001098209.2 | chr3:g.41224645_41224647delTCT | c.133_135delTCT | p.S45delS | RefSeq | GRCh38/hg38 |
XM_047447480.1 | chr3:g.41224645_41224647delTCT | c.133_135delTCT | p.S45delS | RefSeq | GRCh38/hg38 |
XM_024453357.1 | chr3:g.41224645_41224647delTCT | c.133_135delTCT | p.S45del | RefSeq | GRCh38/hg38 |
XM_047447478.1 | chr3:g.41224645_41224647delTCT | c.133_135delTCT | p.S45delS | RefSeq | GRCh38/hg38 |
NM_001098209.1 | chr3:g.41224645_41224647delTCT | c.133_135delTCT | p.S45del | RefSeq | GRCh38/hg38 |
NM_001098209 | chr3:g.41224645_41224647delTCT | c.133_135delTCT | p.S45del | RefSeq | GRCh38/hg38 |
XM_024453356.2 | chr3:g.41224645_41224647delTCT | c.133_135delTCT | p.S45delS | RefSeq | GRCh38/hg38 |
XM_006712985.2 | chr3:g.41224645_41224647delTCT | c.133_135delTCT | p.S45delS | RefSeq | GRCh38/hg38 |
XM_005264886 | chr3:g.41224645_41224647delTCT | c.133_135delTCT | p.S45del | RefSeq | GRCh38/hg38 |
XM_024453356.1 | chr3:g.41224645_41224647delTCT | c.133_135delTCT | p.S45del | RefSeq | GRCh38/hg38 |
NM_001098210.1 | chr3:g.41224645_41224647delTCT | c.133_135delTCT | p.S45del | RefSeq | GRCh38/hg38 |
XM_006712985 | chr3:g.41224645_41224647delTCT | c.133_135delTCT | p.S45del | RefSeq | GRCh38/hg38 |
XM_047447483.1 | chr3:g.41224645_41224647delTCT | c.133_135delTCT | p.S45delS | RefSeq | GRCh38/hg38 |
XM_017005738.1 | chr3:g.41224645_41224647delTCT | c.133_135delTCT | p.S45del | RefSeq | GRCh38/hg38 |
XM_047447482.1 | chr3:g.41224666_41224668delCCT | c.133_135delCCT | p.P45delP | RefSeq | GRCh38/hg38 |
XM_017005738 | chr3:g.41224645_41224647delTCT | c.133_135delTCT | p.S45del | RefSeq | GRCh38/hg38 |
NM_001904.4 | chr3:g.41224645_41224647delTCT | c.133_135delTCT | p.S45delS | RefSeq | GRCh38/hg38 |
NM_001904.3 | chr3:g.41224645_41224647delTCT | c.133_135delTCT | p.S45del | RefSeq | GRCh38/hg38 |
XM_047447477.1 | chr3:g.41224645_41224647delTCT | c.133_135delTCT | p.S45delS | RefSeq | GRCh38/hg38 |
NM_001098210 | chr3:g.41224645_41224647delTCT | c.133_135delTCT | p.S45del | RefSeq | GRCh38/hg38 |
XM_017005738.2 | chr3:g.41224645_41224647delTCT | c.133_135delTCT | p.S45delS | RefSeq | GRCh38/hg38 |
NM_001330729.2 | chr3:g.41224666_41224668delCCT | c.133_135delCCT | p.P45delP | RefSeq | GRCh38/hg38 |
XM_047447481.1 | chr3:g.41224645_41224647delTCT | c.133_135delTCT | p.S45delS | RefSeq | GRCh38/hg38 |
XM_024453358.1 | chr3:g.41224645_41224647delTCT | c.133_135delTCT | p.S45del | RefSeq | GRCh38/hg38 |
XM_006712985.1 | chr3:g.41224645_41224647delTCT | c.133_135delTCT | p.S45del | RefSeq | GRCh38/hg38 |
NM_001904 | chr3:g.41224645_41224647delTCT | c.133_135delTCT | p.S45del | RefSeq | GRCh38/hg38 |
XM_047447479.1 | chr3:g.41224645_41224647delTCT | c.133_135delTCT | p.S45delS | RefSeq | GRCh38/hg38 |
NM_001098210.2 | chr3:g.41224645_41224647delTCT | c.133_135delTCT | p.S45delS | RefSeq | GRCh38/hg38 |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|---|---|---|---|---|---|---|
CTNNB1 S45del | colon carcinoma | predicted - sensitive | NMS-P715 | Preclinical - Cell culture | Actionable | In a preclinical study, cell lines harboring CTNNB1 hotspot mutations, including a colon carcinoma cell line harboring CTNNB1 S45del, demonstrated increased sensitivity to NMS-P715 compared to cell lines with wild-type CTNNB1 in culture (PMID: 28751540). | 28751540 |
CTNNB1 S45del | colon carcinoma | predicted - sensitive | Mps1-IN-1 | Preclinical - Cell culture | Actionable | In a preclinical study, cell lines harboring CTNNB1 hotspot mutations, including a colon carcinoma cell line harboring CTNNB1 S45del, demonstrated increased sensitivity to Mps1-IN-1 compared to cell lines with wild-type CTNNB1 in culture (PMID: 28751540). | 28751540 |
CTNNB1 S45del | colon carcinoma | predicted - sensitive | BAY1161909 | Preclinical - Cell culture | Actionable | In a preclinical study, cell lines harboring CTNNB1 hotspot mutations, including a colon carcinoma cell line harboring CTNNB1 S45del, demonstrated increased sensitivity to BAY1161909 compared to cell lines with wild-type CTNNB1 in culture (PMID: 28751540). | 28751540 |
CTNNB1 S45del | colorectal adenocarcinoma | predicted - sensitive | BAY1161909 | Preclinical - Cell culture | Actionable | In a preclinical study, cell lines harboring CTNNB1 hotspot mutations, including a colorectal adenocarcinoma cell line harboring CTNNB1 S45del, demonstrated increased sensitivity to BAY1161909 compared to cell lines with wild-type CTNNB1 in culture (PMID: 28751540). | 28751540 |
CTNNB1 S45del | colon carcinoma | predicted - sensitive | BAY1217389 | Preclinical - Cell culture | Actionable | In a preclinical study, cell lines harboring CTNNB1 hotspot mutations, including a colon carcinoma cell line harboring CTNNB1 S45del, demonstrated increased sensitivity to BAY1217389 compared to cell lines with wild-type CTNNB1 in culture (PMID: 28751540). | 28751540 |
CTNNB1 S45del | colon carcinoma | predicted - sensitive | Mps-BAY2b | Preclinical - Cell culture | Actionable | In a preclinical study, cell lines harboring CTNNB1 hotspot mutations, including a colon carcinoma cell line harboring CTNNB1 S45del, demonstrated increased sensitivity to Mps-BAY2b compared to cell lines with wild-type CTNNB1 in culture (PMID: 28751540). | 28751540 |
CTNNB1 S45del | colon carcinoma | predicted - sensitive | MPI-0479605 | Preclinical - Cell culture | Actionable | In a preclinical study, cell lines harboring CTNNB1 hotspot mutations, including a colon carcinoma cell line harboring CTNNB1 S45del demonstrated increased sensitivity to MPI-0479605 compared to cell lines with wild-type CTNNB1 in culture (PMID: 28751540). | 28751540 |
CTNNB1 S45del | colon carcinoma | predicted - sensitive | NTRC 0066-0 | Preclinical - Cell culture | Actionable | In a preclinical study, cell lines harboring CTNNB1 hotspot mutations, including a colon carcinoma cell line harboring CTNNB1 S45del, demonstrated increased sensitivity to NTRC 0066-0 compared to cell lines with wild-type CTNNB1 or an isogenic cell line lacking the CTNNB1 mutation, in culture (PMID: 28751540). | 28751540 |